Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02247596Phase 2Completed
Phase 2, randomised, double-blind trial in obesity comparing Resveratrol with Placebo (2 arms). Primary endpoint: Resting Energy Expenditure at 2 weeks. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02247596.